Abstract
Purpose
Acute myeloblastic leukemia with minimally differentiation (AML-M0) is a subtype of acute leukemia with poor prognosis. The recent studies have shown that long non-coding RNAs (lncRNAs) play an important role in different cellular processes, such as cell cycle control and proliferation. Plasmacytoma variant translocation 1 (PVT1) is one of those lncRNAs that is significantly upregulated in AML. LncRNAs could be downregulated or blocked by locked nucleic acids (LNA) which are oligonucleotide strands.
Methods
In this study, lncRNA PVT1 was blocked by antisense LNA GapmeRs in human bone marrow cancerous blast cells. Cells were transfected with PVT1 antisense LNA GapmeRs at 24, 48, and 72 h post-transfection. Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) was accomplished to evaluate the PVT1 and c-Myc expression. Cell viability was evaluated by MTT assay, and apoptosis and necrosis were assessed by Annexin V/propidium iodide staining assay.
Results
The results of this study indicated that the downregulation of PVT1 in blast cells could induce apoptosis, and necrosis and reduce cell viability. The expression of c-Myc was downregulated by blockage of PVT1 and it shows that the expression of these two genes are correlated.
Conclusion
The findings declare that inhibition of PVT1 could be a new target in the treatment of AML-M0 and help to approach more to treatments with fewer side effects.
Similar content being viewed by others
References
Cruz-Miranda GM, Hidalgo-Miranda A, Bárcenas-López DA, Núñez-Enríquez JC, Ramírez-Bello J, Mejía-Aranguré JM, et al. Long non-coding RNA and acute Leukemia. Int J Mol Sci. 2019;20:735.
Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155–9.
Salehi M, Sharifi M. Induction of apoptosis and necrosis in human acute erythroleukemia cells by inhibition of long non-coding RNA PVT1. Mol Biol Res Commun. 2018;7:89–96.
Yao R-W, Wang Y, Chen L-L. Cellular functions of long noncoding RNAs. Nat Cell Biol. 2019;21:542–51.
Ng M, Heckl D, Klusmann J-H. The regulatory roles of long noncoding RNAs in acute myeloblastic Leukemia. Front Oncol 2019;9(570). https://doi.org/10.3389/fonc.2019.00570.
Fernandes J, Acuña S, Aoki J, Floeter-Winter L, Muxel S. Long non-coding RNAs in the regulation of gene expression: physiology and disease. Non-Coding RNA. 2019;5:17.
Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol. 2011;21:354–61.
Enayatrad M, Mirzaei M, Salehiniya H, Karimirad MR, Vaziri S, Mansouri F, et al. Trends in incidence of common cancers in Iran. Asian Pac J Cancer Prev. 2016;17:39–42.
Liu Y, Cheng Z, Pang Y, Cui L, Qian T, Quan L, et al. Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloblastic leukemia. J Hematol OncolJ Hematol Oncol. 2019;12:51.
Short NJ, Rytting ME, Cortes JE. Acute myeloblastic leukaemia. The Lancet. 2018;392:593–606.
Kouchkovsky ID, Abdul-Hay M. Acute myeloblastic leukemia: a comprehensive review and 2016 update. Blood Cancer J. 2016;6:e441–e44141.
Stasi R, Amadori S. AML-M0: a review of laboratory features and proposal of new diagnostic criteria. Blood Cells Mol Dis. 1999;25:120–9.
Yan X, Hu Z, Feng Y, Hu X, Yuan J, Zhao SD, et al. Comprehensive genomic characterization of long non-coding RNAs across human cancers. Cancer Cell. 2015;28:529–40.
Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77:3965–81.
Jin K, Wang S, Zhang Y, Xia M, Mo Y, Li X, et al. Long non-coding RNA PVT1 interacts with MYC and its downstream molecules to synergistically promote tumorigenesis. Cell Mol Life Sci. 2019;76:4275–89.
Tang J, Li Y, Sang Y, Yu B, Lv D, Zhang W, et al. LncRNA PVT1 regulates triple-negative breast cancer through KLF5/beta-catenin signaling. Oncogene. 2018;37:4723–34.
Zhao L, Kong H, Sun H, Chen Z, Chen B, Zhou M. LncRNA-PVT1 promotes pancreatic cancer cells proliferation and migration through acting as a molecular sponge to regulate miR-448. J Cell Physiol. 2018;233:4044–55.
Yu C, Longfei L, Long W, Feng Z, Chen J, Chao L, et al. LncRNA PVT1 regulates VEGFC through inhibiting miR-128 in bladder cancer cells. J Cell Physiol. 2019;234:1346–53.
Cui M, You L, Ren X, Zhao W, Liao Q, Zhao Y. Long non-coding RNA PVT1 and cancer. Biochem Biophys Res Commun. 2016;471:10–4.
Colombo T, Farina L, Macino G, Paci P. PVT1: a rising star among oncogenic long noncoding RNAs. BioMed res int. 2015;2015:304208. https://doi.org/10.1155/2015/304208.
Koch T. LNA antisense: a review. Curr Phys Chem. 2013;3(1):55–68.
Ørum H, Wolter A, Kongsbak L. Locked nucleic acids (LNA) and medical applications. Lett Pept Sci. 2003;10:325–34.
Salehi M, Sharifi M, Bagheri M. Knockdown of long noncoding RNA plasmacytoma variant translocation 1 with antisense locked Nucleic Acid GapmeRs exerts tumor-suppressive functions in human acute erythroleukemia cells through downregulation of C-MYC expression. Cancer Biother Radiopharm. 2019;34:371–9.
Lai C, Doucette K, Norsworthy K. Recent drug approvals for acute myeloblastic leukemia. J Hematol OncolJ Hematol Oncol. 2019;12:100.
Winer ES, Stone RM. Novel therapy in Acute myeloblastic leukemia (AML): moving toward targeted approaches. Ther Adv Hematol. 2019;10:2040620719860645.
Wu Z, Gao S, Zhao X, Chen J, Keyvanfar K, Feng X, et al. Long noncoding RNAs of single hematopoietic stem and progenitor cells in healthy and dysplastic human bone marrow. Haematologica. 2019;104:894–906.
Delás MJ, Sabin LR, Dolzhenko E, Knott SR, Munera Maravilla E, Jackson BT, et al. lncRNA requirements for mouse acute myeloblastic leukemia and normal differentiation. Valcárcel J, editor. eLife. 2017;6:e25607.
Yang Y-R, Zang S-Z, Zhong C-L, Li Y-X, Zhao S-S, Feng X-J. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer. Int J Clin Exp Pathol. 2014;7:6929–35.
Pan X, Cheng R, Zhu X, Cai F, Zheng G, Li J et al. Prognostic significance and diagnostic value of overexpressed lncRNA PVT1 in colorectal cancer. Clin lab. 2019;65(12).
Kong R, Zhang E, Yin D, You L, Xu T, Chen W, et al. Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16. Mol Cancer. 2015;14:82.
Acknowledgements
This study was conducted with the financial support of Isfahan University of Medical Sciences (IRAN) with Grant Number 396877.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This study was approved by the local ethics committee of Isfahan University of Medical Sciences (IRAN) and the study has been approved by the appropriate institutional and/or national research ethics committee and have been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ghadiri, A., Sharifi, M., Mehrzad, V. et al. Reduce proliferation of human bone marrow cells from acute myeloblastic leukemia with minimally differentiation by blocking lncRNA PVT1. Clin Transl Oncol 22, 2103–2110 (2020). https://doi.org/10.1007/s12094-020-02360-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-020-02360-4